Related Experiment Video
Updated: May 13, 2026
Spinal Cord Neurons Isolation and Culture from Neonatal Mice
Published on: July 11, 2017
Altered microRNA expression in the ischemic-reperfusion spinal cord with atorvastatin therapy
Jia-Rui Hu1, Guo-Hua Lv, Bang-Liang Yin
1Department of Spine Surgery, the Second Xiangya Hospital of Central South University, PR China.
Abstract:
We explored the neuroprotection by atorvastatin in the ischemia/reperfusion model of rat and its microRNA-related mechanisms. At first, we uncovered a previously unknown alteration in temporal expression of a large set of microRNAs following spinal cord ischemia-reperfusion injury (IRI). The target genes for the differentially expressed microRNAs include genes encoding components that are involved in the inflammation, apoptosis, and neural damage that are known to play important roles in IRI. Atorvastatin pretreatment restored part of the up or down regulations. These findings suggest that altered expression of microRNAs may contribute to the mechanism of neuroprotection of statins in spinal cord IRI.
Insights
Atorvastatin shows neuroprotection in spinal cord injury by regulating microRNA expression. This study reveals how microRNAs are altered after ischemia-reperfusion injury and how atorvastatin impacts these changes.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Spinal cord ischemia-reperfusion injury (IRI) causes significant neural damage.
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in cellular processes.
- Statins, like atorvastatin, are known for their pleiotropic effects, including potential neuroprotection.
Purpose of the Study:
- To investigate the neuroprotective mechanisms of atorvastatin in a rat model of spinal cord IRI.
- To identify alterations in microRNA expression following spinal cord IRI.
- To explore the role of these microRNA changes in atorvastatin's neuroprotective effects.
Main Methods:
- Induction of spinal cord ischemia-reperfusion injury in a rat model.
- Analysis of temporal microRNA expression profiles post-injury.
- Bioinformatic analysis to identify target genes of differentially expressed miRNAs.
- Assessment of atorvastatin's effect on microRNA expression and neuroprotection.
Main Results:
- Spinal cord IRI induced significant temporal alterations in a wide range of microRNAs.
- Target genes of these dysregulated miRNAs are involved in inflammation, apoptosis, and neural damage pathways.
- Atorvastatin pretreatment partially reversed these microRNA expression changes.
- Atorvastatin demonstrated neuroprotective effects in the IRI model.
Conclusions:
- Altered microRNA expression is a key component of the pathophysiology of spinal cord IRI.
- Atorvastatin's neuroprotective effects in spinal cord IRI may be mediated, in part, by modulating microRNA expression.
- This study highlights a novel miRNA-related mechanism for statin neuroprotection.
